Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03409367 · ClinicalTrials.gov registry record · NA
A Community-based Assessment of Skin Care, Allergies, and Eczema
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 1,260
- Enrollment target
NCT03409367 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 1,260 participants.
The verdict
NCT03409367, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,260 participants
- Enrollment target
Study Summary
Atopic dermatitis (AD) affects over 9 million children in the U.S. and often heralds the development of asthma, food allergy, skin infections and neurodevelopmental disorders. Recent advances identify skin barrier dysfunction to be the key initiator of AD and possibly allergic sensitization. Our central hypothesis is that daily emollient use from birth can prevent the development of AD in a community setting and into newborns unselected for risk. The results of a community-based clinical trial utilizing a pragmatic trial design will be immediately applicable to the population at large and will establish a new standard of care for all newborns.
Interventions
- OTHER Participant choice of over-the-counter emollients: Vaseline, Vanicream, CeraVe Healing Ointment, CeraVe cream, Cetaphil cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,260 participants |
| Start Date | 2018-07-16 |
| Est. Completion | 2024-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03409367
The ClinicalTrials.gov registry entry for NCT03409367 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Participant choice of over-the-counter emollients: Vaseline, Vanicream, CeraVe Healing Ointment, CeraVe cream, Cetaphil cream is the first listed.
NCT03409367 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03409367 about?
NCT03409367 is a clinical study titled "A Community-based Assessment of Skin Care, Allergies, and Eczema". Atopic dermatitis (AD) affects over 9 million children in the U.S. and often heralds the development of asthma, food allergy, skin infections and neurodevelopmental disorders. Recent advances identify skin barrier dysfunction to be the key initiator of AD and possibly allergic sensitization. Our ce...
What is the current status of trial NCT03409367?
This trial is currently completed. It is a NA study. The enrollment target is 1,260 participants. The study started on 2018-07-16. Estimated completion is 2024-01-31.
What interventions are being tested in trial NCT03409367?
The interventions under investigation include: Participant choice of over-the-counter emollients: Vaseline, Vanicream, CeraVe Healing Ointment, CeraVe cream, Cetaphil cream (OTHER).
Who is sponsoring clinical trial NCT03409367?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.